Hims vs Willow: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats Hims overall, scoring 8.2/10 vs 7.9/10. Hims is more affordable at $175/mo vs $299/mo. Choose Hims for men who want glp-1 access from a well-known, publicly traded. Choose Willow for users who want a balance of quality care and reasonable pric.
A side-by-side comparison of Hims and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 40One of the largest and most recognized men's telehealth platforms in the US, offering compounded GLP-1 medications with a polished app experience and strong brand trust.
Visit HimsWillow
#8 of 40Personalized GLP-1 weight loss with ongoing clinical support. The highest verified conversion rate among comprehensive care platforms.
Visit Willow| Feature | Hims | Willow |
|---|---|---|
| Our Score | 7.9/10 | 8.2/10 |
| Starting Price | $175/mo | $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 access from a well-known, publicly traded telehealth brand | Users who want a balance of quality care and reasonable pricing |
| Ranking | #12 | #8 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in men's telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition and extensive customer support infrastructure
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Switch between brand-name and compounded mid-treatment without restarting
- +$160/mo all-in — no consultation fees, no shipping charges, no lab surcharges
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Hims with a score of 8.2/10 vs 7.9/10. If budget is your priority, Hims starts at $175/mo compared to Willow's $299/mo. Willow offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Willow if you want: users who want a balance of quality care and reasonable pricing.